TOPLINE: In an interim analysis of a phase 2/3 study, neoadjuvant therapy with gemcitabine–oxaliplatin, lenvatinib, and toripalimab (GOLP regimen) more than doubled the median event-free survival […]
TOPLINE: In patients with glaucoma, preoperative use of the alpha-agonist brimonidine is associated with a nearly threefold increased risk for trabeculectomy failure due to elevated intraocular […]
TOPLINE: In a phase 2 study, neoadjuvant sacituzumab govitecan plus pembrolizumab achieved a promising clinical complete response rate and had a favourable safety profile in patients […]
TOPLINE: In outpatient care, children younger than 2 years who tested positive for respiratory syncytial virus (RSV) infection had higher rates of wheezing, crackles, and tachypnoea […]
TOPLINE: A high proportion of patients with rheumatoid arthritis (RA) exhibited sleep impairment. Treatment with upadacitinib improved patient-reported sleep quality at 3 months, with benefits sustained […]
TOPLINE: State Medicaid expansion was associated with a lower risk for death within 2 years and a higher likelihood of surgical resection among adults with pancreatic […]
TOPLINE: Major depressive disorder (MDD) was prevalent among 32% of all individuals with cannabis use disorder (CUD) in a new meta-analysis, and CUD was prevalent among […]
TOPLINE: Adult patients with Cushing syndrome who completed a 22-week trial of relacorilant therapy and continued treatment for 12 additional weeks preserved hypertension control and sustained […]
TOPLINE: A few exhaled volatile organic compounds — specifically decane and nonadecane — showed potential to identify allergic patients among those with chronic rhinitis, with 76.5% […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.